Two New IL-1β Drugs Just Launched in China. What Firsekibart and Anfulitamab Mean for Gout

Two New IL-1β Drugs Just Launched in China. Here Is What They Mean for Gout Treatment Worldwide You probably have not heard of either of these drugs yet. Their names are firsekibart and anfulitamab, and both were approved in China over the past fourteen months for acute gout flares. They target IL-1β, the same inflammatory … Read more

When Every Gout Drug Is Bad for Your Kidneys: Can Canakinumab Fill the Gap?

Your kidney function is down to 30 percent. Your big toe feels like someone drove a nail through it. The doctor says no to ibuprofen. Colchicine is risky too. Even a steroid shot comes with caveats. What are you supposed to do when every standard gout treatment is off the table? This is the reality … Read more